公募基金方面，本期较上一期持股增加的公募基金共计2个，包括泰康丰盈债券A、路博迈中国医疗健 康股票发起A，持股增加占比小幅上涨。本期较上一季度持股减少的公募基金共计3个，包括国泰医药 健康股票A、国泰大健康股票A、泰康医疗健康股票发起A，持股减少占比达0.24%。本期较上一季度新 披露的公募基金共计4个，包括南方中证1000ETF、鑫元聚鑫收益增强A、鑫元鑫领航混合A、红塔红土 盛商一年定期开放债券A。本期较上一季未再披露的公募基金共计7个，主要包括中欧医疗健康混合A、 南方中证500ETF、汇丰晋信新动力混合A、财通资管健康产业混合A、汇添富中证互联网医疗指数 (LOF)A等。 2025年8月26日，老百姓(603883.SH)发布2025年半年度报告。截至2025年8月25日，共有14个机构投资 者披露持有老百姓A股股份，合计持股量达3.94亿股，占老百姓总股本的51.87%。其中，前十大机构投 资者包括老百姓医药集团有限公司、泽星投资有限公司、香港中央结算有限公司、林芝腾讯科技有限公 司、中国人寿保险股份有限公司-传统-普通保险产品-005L-CT001沪、招商银行股份有限公司-南方中证 1000交易型 ...

Group 1 - The core viewpoint of the news is that the institutional ownership of Laobaixing (603883.SH) has increased, with 17 institutional investors holding a total of 423 million shares, representing 55.65% of the total share capital as of April 30, 2025 [1] - The top ten institutional investors collectively hold 55.05% of the shares, with an increase of 1.19 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds increased their holdings, accounting for a 1.28% increase, while one fund saw a slight decrease in holdings [2] - Eight new public funds were disclosed during this period, including several focused on healthcare and medical sectors [2] - One insurance fund decreased its holdings slightly, while one pension fund was no longer disclosed [2]